Trademark Attorney / Law Firm
COLIN CHRISTOPHER HOLLEY – Trademark Portfolio
COLIN CHRISTOPHER HOLLEY specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 11 of 18 total filings concentrated in this category. The practice also covers Class 3 (Cosmetics & Cleaning) along with 3 other Nice Classification classes. Filing activity spans from 2025 to 2026. Currently, 2 trademarks are registered and 12 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
COLIN CHRISTOPHER HOLLEY's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademark applications has COLIN CHRISTOPHER HOLLEY filed?
COLIN CHRISTOPHER HOLLEY has filed 18 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered, 12 pending, 4 abandoned.
What trademark classes does COLIN CHRISTOPHER HOLLEY specialize in?
COLIN CHRISTOPHER HOLLEY has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 12 (Vehicles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has COLIN CHRISTOPHER HOLLEY been filing trademarks?
COLIN CHRISTOPHER HOLLEY's trademark filing history with the USPTO spans from 2025 to 2026, covering 1 year of trademark practice. During this period, COLIN CHRISTOPHER HOLLEY has handled 18 trademark applications.
What is COLIN CHRISTOPHER HOLLEY's trademark registration success rate?
COLIN CHRISTOPHER HOLLEY has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 12 applications are pending review.